本页面由Tiger Trade Technology Pte. Ltd.提供服务

Catalyst Pharmaceutical Partners

24.69
-0.1300-0.52%
盘后24.760.0700+0.28%18:27 EDT
成交量:61.61万
成交额:1,518.14万
市值:30.15亿
市盈率:14.70
高:24.79
开:24.54
低:24.38
收:24.82
52周最高:26.58
52周最低:19.05
股本:1.22亿
流通股本:1.15亿
量比:0.64
换手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):1.68
每股收益(LYR):1.68
净资产收益率:25.49%
总资产收益率:16.48%
市净率:3.16
市盈率(LYR):14.70

数据加载中...

2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans